Genetic Testing in Patients with Hypertrophic Cardiomyopathy
Open Access
- 27 September 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10401
Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with an estimated prevalence of up to 1 in 200 individuals. In the majority of cases, HCM is considered a Mendelian disease, with mainly autosomal dominant inheritance. Most pathogenic variants are usually detected in genes for sarcomeric proteins. Nowadays, the genetic basis of HCM is believed to be rather complex. Thousands of mutations in more than 60 genes have been described in association with HCM. Nevertheless, screening large numbers of genes results in the identification of many genetic variants of uncertain significance and makes the interpretation of the results difficult. Patients lacking a pathogenic variant are now believed to have non-Mendelian HCM and probably have a better prognosis than patients with sarcomeric pathogenic mutations. Identifying the genetic basis of HCM creates remarkable opportunities to understand how the disease develops, and by extension, how to disrupt the disease progression in the future. The aim of this review is to discuss the brief history and recent advances in the genetics of HCM and the application of molecular genetic testing into common clinical practice.Keywords
Funding Information
- Conceptual Development of Research Organization, Motol University Hospital, Prague (grant No. 00064203)
- Ministerstvo Zdravotnictví Ceské Republiky (grant No. 15-34904A)
This publication has 103 references indexed in Scilit:
- Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic CardiomyopathyCirculation: Cardiovascular Genetics, 2013
- Cardiac Remodeling in ObesityCirculation: Cardiovascular Imaging, 2013
- Penetrance of Hypertrophic Cardiomyopathy in Children and AdolescentsCirculation, 2013
- Identifying Sarcomere Gene Mutations in Hypertrophic CardiomyopathyCirculation Research, 2011
- Clinical Challenges of Genotype Positive (+)–Phenotype Negative (−) Family Members in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2011
- Genetics and Clinical Destiny: Improving Care in Hypertrophic CardiomyopathyCirculation, 2010
- Sudden Deaths in Young Competitive AthletesCirculation, 2009
- Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relativesHuman Mutation, 2008
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990
- Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1New England Journal of Medicine, 1989